News

Trump aims tariff double whammy at industries and nations
President Trump is readying plans for industry-specific tariffs to kick in alongside his country-by-country duties in two ...
Billionaire Stanley Druckenmiller Sold His Entire Stake in Palantir and Has Loaded Up on These 2 Exceptional Stocks for 3 Consecutive Quarters
Duquesne Family Office's billionaire chief dumped his fund's stake in Wall Street's artificial intelligence (AI) darling in ...
The Healthy @Reader's Digest on MSN3d
More than 57,000 Bottles of a Cholesterol Medication Have Been Recalled in One State
Millions of Americans rely daily on this type of heart-helping medication. See if this newly provided alert impacts your prescription.
Goldman Sachs Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA)
Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.
Leader Capital Markets Sticks to Its Buy Rating for Teva (TEVA)
Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.
Verona Pharma plc (VRNA): A Bull Case Theory
We came across a bullish thesis on Verona Pharma plc (VRNA) on Capital Employed’s Substack by Patients Capital Management. In ...
pharmaphorum6d
Post-hype, pre-value: The real AI-pharma shift starts now
By 2023, the tone had shifted. Venture capital cooled. According to CB Insights, funding for AI drug discovery start-ups ...